Tuesday, October 21, 2014

Elite Pharmaceuticals Inc. - Blogger Analysis

Elite Pharmaceuticals, ticker symbol ELTP, is receiving a high rating this evening from me.  In full disclosure, I own no shares of the company and have not been paid to promote it.

The company is generating over a million dollars of revenue per quarter, and is wisely investing in R&D to propel future growth.  The stock is attractively valued at only .29 per share and I believe that now is a great time to buy shares of it.  I firmly believe that this stock could potentially reach $1 per share in price in short order.

No comments:

Post a Comment